Johnson & Johnson Offers Weak Outlook, May Look To Sell Diabetes Units

From Johnson & Johnson (NYSE:JNJ) early Tuesday posted mixed fourth quarter results, offered a tepid outlook, and said it would look to sell its diabetes treatment units.
NYSE:JNJ January 24, 2017 7:11am

Report: Johnson & Johnson Boosts Bid For Actelion

In a sign that a deal could be close to being struck, healthcare products giant Johnson & Johnson (NYSE:JNJ) has reportedly upped its takeover offer for European biotech giant Actelion.
NYSE:JNJ November 29, 2016 10:56am

Johnson & Johnson Boosts Outlook as Q3 Earnings Beat Estimates

JNJ logoHealth care giant Johnson & Johnson (NYSE:JNJ) early today posted better-than-expected third quarter earnings results and lifted its full-year guidance.
NYSE:JNJ October 18, 2016 7:10am

Election Cloud Could Soon Lift for Healthcare ETFs

pills healthcare 600X300Another quarter and another superb performance from pharmaceutical giant Johnson & Johnson (NYSE:JNJ). For the most part, healthcare ETFs have been performing in-line with the markets. Investors looking to avoid volatility tend to gravitate toward the big pharma plays.
JNJ July 19, 2016 11:47am

Get Free Updates

Join over 50,000 investors who get the latest news from!

Most Popular

From Our Partners

Explore More from

Free Daily Newsletter

Get daily ETF insights from our market experts. Never miss another important market development again! respects your privacy.

Best ETFs

We've rated and ranked nearly 2,000 ETFs and ETNs using our proprietary SMART Grade system.

View Top Rated ETFs

Best Categories

We've ranked dozens of ETF categories based on relative performance.

Best ETF Categories